SanBio Co Ltd
TSE:4592
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
SanBio Co Ltd
TSE:4592
|
JP |
|
C
|
Coloplast A/S
F:CBHD
|
DK |
|
N
|
Northern Lion Gold Corp
XTSX:NL
|
CA |
|
Saunders International Ltd
ASX:SND
|
AU |
|
Bunge Global SA
F:Q23
|
US |
|
Cicor Technologies Ltd
F:CRLN
|
CH |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
CN |
|
X-Legend Entertainment Co Ltd
TWSE:4994
|
TW |
|
Takasago Thermal Engineering Co Ltd
TSE:1969
|
JP |
Intrinsic Value
Is SanBio Co Ltd undervalued or overvalued?
See the intrinsic value estimate for
SanBio Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What SanBio Does
SanBio Co Ltd is a Japanese biotechnology company focused on regenerative medicine. It develops cell-based therapies designed to repair damaged tissue, especially for serious conditions affecting the brain and central nervous system. Its main products are experimental and approved cell treatments built around its own cell-processing and manufacturing know-how.
- Headquarters
- Japan JP
- Employees
- 33
- IPO date
- Apr 8, 2015
SanBio has no economic moat
SanBio Co Ltd lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysis
Revenue & Expenses Breakdown
SanBio Co Ltd
Earnings Waterfall
SanBio Co Ltd
The intrinsic value for
SanBio Co Ltd (4592) under the Base Case is hidden JPY.
Compared with the current market price of 917 JPY, the stock appears hidden.